Difficulty: Medium
Average Score: 77%
Practice
Which of the following is the leading cause of death among women?
Correct answer
C
Rationale
In the context of pharmacology and health promotion, understanding the leading causes of death among women is crucial for healthcare professionals to provide targeted interventions and education. The correct answer, Coronary artery disease (CAD) (Option C), is the leading cause of death among women globally. CAD is a significant public health concern due to factors like lifestyle choices, genetics, and hormonal influences. Women often present with atypical symptoms of CAD, leading to underdiagnosis and undertreatment.
Option A, Accidents, while a significant cause of mortality, is not the leading cause of death among women. Option B, Cancer, is a prevalent health issue for women but does not surpass CAD in terms of mortality rates. Option D, Stroke, is a leading cause of death but typically ranks below CAD in women.
Educationally, emphasizing CAD as the primary cause of death among women underscores the importance of cardiovascular health promotion, risk factor management, and early detection strategies in clinical practice. Pharmacological interventions for CAD, such as lipid-lowering agents and antiplatelet therapy, play a vital role in preventing adverse cardiovascular events in women. Understanding these distinctions equips healthcare providers to address women's unique health needs effectively.
Option A, Accidents, while a significant cause of mortality, is not the leading cause of death among women. Option B, Cancer, is a prevalent health issue for women but does not surpass CAD in terms of mortality rates. Option D, Stroke, is a leading cause of death but typically ranks below CAD in women.
Educationally, emphasizing CAD as the primary cause of death among women underscores the importance of cardiovascular health promotion, risk factor management, and early detection strategies in clinical practice. Pharmacological interventions for CAD, such as lipid-lowering agents and antiplatelet therapy, play a vital role in preventing adverse cardiovascular events in women. Understanding these distinctions equips healthcare providers to address women's unique health needs effectively.